Tianshan Biological Semi -annual net profit of 13.1292 million yuan increased by 10.45% year -on -year

On August 18th, Tianshan Biological (Code: 837485.NQ) released the performance report of the 2022 Half -Annual Report.

From January 1, 2022-June 30, 2022, the company realized operating income of 50.264 million yuan, a year-on-year decrease of 10.37%, and net profit was 13.1292 million yuan, an increase of 10.45%year-on-year, and the basic earnings per share were 0.3200 yuan.

The company's industry is the planting and forestry.

During the company's reporting period, the total assets at the end of the period were 153 million yuan, the operating profit was 13.2536 million yuan, the accounts receivable were 1.6741 million yuan, and the net cash flow generated by operating activities was -180.73 million yuan.The cash was 17.8615 million yuan.

Tiangu Biological, the company's full name, Shanghai Tianshan Biotechnology Co., Ltd., was established on March 29, 2011. It is currently the general manager Jin Zuping. The main business is the research and development, sales and technical services of water -saving drought -resistant rice series products.

- END -